Elicio raises ~$4.9M from ATM equity sales since Q3 2023

Elicio Therapeutics, Inc.

Issued and sold 584,170 shares under at-the-market program since September 30, 2023.
Net proceeds of approximately $4.89 million after deducting sales commissions.
Original ATM program authorized up to $21.0 million in aggregate offering price.
Program is ongoing with Stifel and Virtu Americas LLC as agents.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.